To gather information on the exposure of European citizens to chemicals, to support the effective implementation and evaluation of Union legal acts on chemicals and to contribute to the development of a comprehensive Union chemicals policy, the ECHA and the EFSA, in cooperation with the EEA, should commission a Union-wide human biomonitoring study. The Member States should cooperate with the ECHA, the EFSA and the EEA in the planning and organisation of that study, and should provide the necessary technical assistance and administrative support to the parties contracted by the ECHA or the EFSA to carry out the sampling in order to enable sampling in their territories and to ensure that the samples are sufficiently representative. The human biomonitoring study should adhere to ethical and confidentiality standards. Taking into account the experience gained through that human biomonitoring study, the Commission should assess the appropriateness of requiring regular human biomonitoring studies, as well as the resources necessary for such studies and modalities for involving Member States in such studies. Depending on the outcome of that assessment, the Commission should consider presenting a legislative proposal.
Text as published in the Official Journal, reproduced verbatim (including any typographical quirks of the source). For the authentic version, see EUR-Lex.